Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Coates

Showing results (301-310 of 455) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials GroupM J Byrne, V Gebski, J Forbes, et al.
Ecology and Evolution|December 5, 2022
Defining biologically relevant and hierarchically nested population units to inform wildlife managementMichael S O'Donnell, David R Edmunds, Cameron L Aldridge, et al.
Springerplus|September 12, 2013
Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisoneChee Khoon Lee, Val J Gebski, Alan S Coates, et al.
Patient Education and Counseling|April 25, 2008
Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancerVlatka M Duric, Phyllis N Butow, Louise Sharpe, et al.
BMJ (Clinical Research Ed.)|February 4, 1989
Changing character of cervical cancer in young womenP M Elliott, M H Tattersall, M Coppleson, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
ANZ Journal of Surgery|February 13, 2001
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapyP R Kitchen, T H Smith, M A Henderson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2008
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study GroupLorenzo Gianni, Shari Gelber, Alberto Ravaioli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.
Scientific Data|May 2, 2026
A comprehensive inventory of communication tower infrastructure across the range of greater and Gunnison sage-grouseSarah C Webster, Shawn Szabo, Jacqueline B Cupples, et al.
Pageof 46

Showing results (301-310 of 455) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials GroupM J Byrne, V Gebski, J Forbes, et al.
Ecology and Evolution|December 5, 2022
Defining biologically relevant and hierarchically nested population units to inform wildlife managementMichael S O'Donnell, David R Edmunds, Cameron L Aldridge, et al.
Springerplus|September 12, 2013
Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisoneChee Khoon Lee, Val J Gebski, Alan S Coates, et al.
Patient Education and Counseling|April 25, 2008
Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancerVlatka M Duric, Phyllis N Butow, Louise Sharpe, et al.
BMJ (Clinical Research Ed.)|February 4, 1989
Changing character of cervical cancer in young womenP M Elliott, M H Tattersall, M Coppleson, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
ANZ Journal of Surgery|February 13, 2001
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapyP R Kitchen, T H Smith, M A Henderson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2008
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study GroupLorenzo Gianni, Shari Gelber, Alberto Ravaioli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.
Scientific Data|May 2, 2026
A comprehensive inventory of communication tower infrastructure across the range of greater and Gunnison sage-grouseSarah C Webster, Shawn Szabo, Jacqueline B Cupples, et al.
Pageof 46